Evaluating Cypriot pharmacist’s knowledge of alcohol-medication interactions
DOI:
https://doi.org/10.60988/pj.v35i3.6Abstract
Background: Many medications can interact when taken with alcohol, thereby altering the metabolism and the medication effects. However, pharmacists’ knowledge about the alcohol-medication interactions have not yet been studied in the Republic of Cyprus.
Objective: Our objective was to examine the pharmacists' knowledge on possible alcohol-medication interactions and to uncover whether they are able to identify and/or counsel patients who may have high-risk alcohol behaviors.
Methods: A self-administered questionnaire was developed, consisting of 37 questions, and distributed to Cypriot community pharmacists of the capital of Cyprus namely, Nicosia. All questions were based on 5-point Likert scale items and collected through electronic response receipts. Three topics were evaluated and critically discussed: (i) Knowledge of community pharmacists about alcohol abuse and ability to counsel; (ii) Knowledge of community pharmacists about alcohol-medication interactions; and (iii) Past experiences of community pharmacists with heavy-alcohol drinkers.
Results: A total of 68 Cypriot pharmacists (males: 48.5% vs. females: 51.5%) participated in this study. Most pharmacists (n=44, 64.7%) agreed that they were confident in advising their patients about the harmful use of alcohol consumption. Some pharmacists (n=26, 38.2%) agreed to discuss the current alcohol guidelines with their patients and having the ability to advise them. Around 57% of the pharmacists (n=39/68) suggested to counsel Cypriot patients about the effects of alcohol-medication interactions. The vast majority of Cypriot pharmacists (85.3%) indicated that warfarin when taken with alcohol can cause "Internal haemorrhage".
Conclusion: This study reports the first results on Cypriot pharmacist’s knowledge and views about alcohol-medication interactions. Although most Cypriot pharmacists are aware of most of the interactions, education should be a priority for community pharmacists in Cyprus in order to utilize primary health servicses.
References
Hovstadius B., Hovstadius K., Åstrand B., Petersson G. Increasing polypharmacy - an individual-based study of the Swedish population 2005-2008. BMC Clin.Pharmacol. 10,16 2010.
Moriarty F., Hardy C., Bennett K., Smith S.M., Fahey T. Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: A repeated cross-sectional study. BMJ Open. 5, e008656, 2015.
Weathermon R., Crabb D.W. Alcohol and medication interactions. Alcohol Res Health. 23(1), 40-54, 1999.
Cousins G., Galvin R., Flood M., Kennedy M.-C., Motterlini N., Henman M.C. et al. Potential for alcohol and drug interactions in older adults: Evidence from the Irish Longitudinal Study on Ageing. BMC Geriatr. 14, 57, 2014.
Chrischilles E.A., Foley D.J., Wallace R.B., Lemke J.H., Semla T.P., Hanlon J.T. et al. Use of medications by persons 65 and over: Data from the established populations for epidemiologic studies of the elderly. J.Gerontol. 47(5) , M137-44, 1992.
Dhital R., Coleman R., Day E., Drummond C., Lingford-Hughes A., Marsden J. et al. Service users’ views and experiences of alcohol relapse prevention treatment and adherence: New role for pharmacists? Alcohol and Alcoholism. 57(5),602–8, 2022.
Dhital R., Whittlesea C.M., Norman I.J., Milligan P. Community pharmacy service users' views and perceptions of alcohol screening and brief intervention. Drug Alcohol Rev. 29(6), 596-602, 2010.
Dhital R., Norman I., Whittlesea C., Murrells T., McCambridge J. The effectiveness of brief alcohol interventions delivered by community pharmacists: Randomized Controlled Trial. Addiction. 110(10), 1586–94, 2015.
Charalampous P., Pallari E., Tyrovolas S., Middleton N., Economou M., Devleesschauwer B. et al. Burden of non-communicable diseases in cyprus, 1990–2017: Findings from the global burden of disease 2017 study. Arch.Public Health. 79(1), 138, 2021.
Cyprus: Country Health Profile 2021 [Internet]. Oecd-ilibrary.org. 2022 [cited 16 September 2022]. Available from: https://www.oecd-ilibrary.org/social-issues-migration-health/cyprus-country-health-profile-2021_c2fe9d30-en;jsessionid=4uHbeIavgOSZq_YwriQT6gjhadDFSOL9lhYYCnY5.ip-10-240-5-115
Nicolaou S.A., Heraclides A., Markides K.S., Charalambous A. Prevalence and social determinants of smoking in the adult Greek Cypriot population. Hippokratia. 20(4), 284-291, 2016. PMID: 29416301
Tobacco Viz [Internet]. Vizhub.healthdata.org. 2022 [cited 16 September 2022]. Available from: https://vizhub.healthdata.org/tobacco/
Christou V., Karataraki F., Diakonikolaou S., Eid O., Eid R., Styliou T. et al. Assessing the prevalence of hypertension in patients with chronic coronary artery disease in cyprus. Eur. J. Prev. Cardiol. 29(Supplement_1), 2022.
Pallari E., Lewison G., Pallari C., Samoutis G., Begum M., Sullivan R. The contribution of Cyprus to non-communicable diseases and biomedical research from 2002 to 2013: implications for evidence-based health policy. Health Res. Policy and Syst. 16(1), 82, 2018.
Hattingh L., Tait R. Pharmacy-based alcohol-misuse services: current perspectives. Integr.Pharm. Res. Pract. 7,21-31, 2018.
McCaig D., Fitzgerald N., Stewart D. Provision of advice on alcohol use in community pharmacy: a cross-sectional survey of pharmacists' practice, knowledge, views and confidence. Int. J. Pharm. Pract. 19(3), 171-178, 2011.
Barnes G., Chappell N. Pharmacists' knowledge in the area of alcohol, and alcohol and drug interactions. Social Science & Medicine Part A: Medical Psychology & Medical Sociology. 15(5), 649-6571981.
Harmful Interactions | National Institute on Alcohol Abuse and Alcoholism (NIAAA) [Internet]. Niaaa.nih.gov. 2022 [cited 16 September 2022]. Available from: https://www.niaaa.nih.gov/publications/brochures-and-fact-sheets/harmful-interactions-mixing-alcohol-with-medicines
Roth J., Bradley K., Thummel K., Veenstra D., Boudreau D. Alcohol misuse, genetics, and major bleeding among warfarin therapy patients in a community setting. Pharmacoepidemiol. Drug Saf. 24(6), 619-627, 2015 .
Johnson B.A., Seneviratne C. (2014) Alcohol–medical drug interactions in Handbook of Clinical Neurology. Sullivan E.V, Pfefferbaum A. (eds), Elsevier
Lenz T. Drug–Alcohol Interactions. Am. J. Lifestyle Med. 7(4), 250-252, 2013 .
Pharmaceutical Services | Home Page [Internet]. Moh.gov.cy. 2022 [cited 16 September 2022]. Available from: https://www.moh.gov.cy/moh/phs/phs.nsf/home_en/home_en?openform https://www.moh.gov.cy/moh/phs/phs.nsf/home_en/home_en?openform
Charalampous P., Peletidi A. Exploring Cypriot Pharmacists' Perceptions about their Role in Cardiovascular Disease Prevention: A Descriptive Qualitative Study. J. Res. Pharm. Pract. 10(1), 23-29, 2021
Johnson N., Kypri K., Attia J. Development of an Electronic Alcohol Screening and Brief Intervention Program for Hospital Outpatients With Unhealthy Alcohol Use. JMIR Research Protocols. 2(2), e36, 2013.
Nilsen P. Brief alcohol intervention-where to from here? Challenges remain for research and practice. Addiction. 105(6), 954-959, 2010; .
